Application 205777

Type
NDA
Sponsor
PURDUE PHARMA LP

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TARGINIQNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL5MG;10MGYesNo
002TARGINIQNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL10MG;20MGYesNo
003TARGINIQNALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL20MG;40MGYesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
55667SUPPL2018-09-28
55666SUPPL2018-09-28
55549SUPPL2018-09-21
55548SUPPL2018-09-21
55547SUPPL2018-09-21
55546SUPPL2018-09-21
48587SUPPL2017-05-31
46576SUPPL2016-12-29
46437SUPPL2016-12-21
46324SUPPL2016-12-20
45454SUPPL2016-10-03
32723SUPPL2016-04-22
24127ORIG2015-11-04
10501SUPPL2015-07-07
44598ORIG2015-06-30
23002ORIG2014-08-27
32722SUPPL2014-08-20
32721ORIG2014-07-23
19684ORIG2014-07-23